NCT05678933: AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH |
|
|
| Enrolling by invitation | 3 | 200 | RoW | Azacitidine, Chidamide, Cyclophosphamide, Epirubicin, Vincristine, Prednisone | Tianjin Medical University Cancer Institute and Hospital | Peripheral T-cell Lymphoma Targeted Therapy | 12/27 | 12/29 | | |
NCT05572983: Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype |
|
|
| Recruiting | 2 | 47 | RoW | Chidamide combined with CHOP, Induction treatment, Chidamide, Maintenance treatment | Sun Yat-sen University | Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype | 09/24 | 09/26 | | |